Greg Crist

People are dying and not being treated with up-to-date technology because of bureaucracy in the Medicare system. Medicare coverage lags years behind FDA approval, meaning people are not getting the treatment they need and deserve. The safety process for drugs and medical devices needs to be rigorous, but once something is proven safe, there is no reason patients shouldn’t have immediate access. Lawmakers must act to prevent this from continuing.

We thank Pres. @realDonaldTrump, @VP Vance, @LeaderJohnThune, @SpeakerJohnson, Chair @MikeCrapo & Chair @JasonSmithMO for the legislation passed today that will without question create a pro-growth environment for America’s #medtech industry to maintain its global leadership. 1/7

I testified in the Senate today on the impact tariffs are having on the #medtech supply chain. We support the President's goals to restore U.S. manufacturing & fix trade imbalances, but here's why medtech is unique when it comes to tariffs: youtube.com/watch?v=IzDF5-…

2/ First, thank you, @SenToddYoung, for your leadership on the bipartisan bill you lead that says if @US_FDA deems a “breakthrough” medical technology to be safe & effective, its coverage path through CMS should be clear, transparent, & expedited for the benefit of patients.

1/ My thoughts on the Senate hearing today on @DrOz's nomination to serve as the next @CMSGov Administrator ... youtube.com/watch?v=kWDgg8…

Up to 41 companies now and it’s gonna be great!

The latest episode of Medtech POV features Venk Varadan a #medtech entrepreneur and the co-founder of @nanowearinc. He discusses the critical role that AdvaMed's @MedTechCon plays for companies looking for investors. Listen to the full episode: apple.co/3Ulvgux

#NEWS: @RepMikeCarey and @RepDannyDavis introduced a bipartisan bill to expand access to FDA-approved breakthrough #medtech to Medicare beneficiaries through NTAP conditional approval policy. bit.ly/3Uen7cv

Good primer on how polling today works. nytimes.com/article/times-…

Ready for ⁦⁦@AdvaMedDx⁩ Exec Dir Zach Rothstein to make a clear case for diagnostic reform today before this E&C hearing. energycommerce.house.gov/events/health-…

Want an insider’s view on how far medtech has come on innovation? The smartest 40 min you’ll spend this week rests right here.

According to @American_Heart, over 11 million Americans are affected by heart valve disease, yet 3 out of 4 know little about it. Listening to your heart is key for early detection and timely treatment. bit.ly/3I9CJY4. #ValveDiseaseDay

AdvaMed’s own Dr. Lishan Aklog about to testify before House Small Business Committee today on impact of EPA regulations and sterilizing medical technologies. ⁦@AdvaMedUpdate⁩

Heart disease is often misdiagnosed in women. Carol Pollard found hope in the @AbbottNews MitraClip, reclaiming her life from cardiac amyloidosis. Tina Marsden received Abbott's HeartMate II, empowering her to advocate for women’s heart health. Read more: fxn.ws/3wcCnwR

Important thoughts on medtech and supply chain for ‘24 ⁦@AdvaMedUpdate⁩ realclearhealth.com/2024/01/04/pre…

On the Empowered Patient Podcast, AdvaMed Board Member, Dr. Lishan Aklog, discusses how life-saving #medtech, like Esoguard, can detect pre-cancerous cells linked to Esophageal cancer in 80% of people. Tune in to learn more: bit.ly/3Rp736e

The power of innovation…making a difference in patient lives. wcti12.com/news/local/gro…

Today's #DeviceOfTheDay features Insulet's @myomnipod. Insulet Corporation is the first medical device manufacturer to develop a tubeless insulin delivery system. Learn more about the latest diabetes #medtech improving patient lives: insulet.com/innovation

Excited to have our members on the Armstrong Williams show to talk #medtech and diabetes treatment with Insulet and ⁦@myomnipod⁩ ⁦@AdvaMedUpdate⁩

#DYK: 91% of adults acknowledge the significant impact of investing in research to treat and cure people living with diabetes. Read more of our key findings: bit.ly/47qwCJc